Literature DB >> 11062011

Mechanisms for the formation of protein-bound homocysteine in human plasma.

T Togawa1, S Sengupta, H Chen, K Robinson, I Nonevski, A K Majors, D W Jacobsen.   

Abstract

Hyperhomocysteinemia is an independent risk factor for cardiovascular disease. Greater than 70% of homocysteine in circulation is protein-bound. An in vitro model system using human plasma has been developed to study mechanisms of protein-bound homocysteine formation and establish the equilibrium binding capacities of plasma for homocysteine. Addition of homocysteine to plasma caused an initial rapid displacement of cysteine and a subsequent increase in protein-bound homocysteine. This rapid reaction was followed by a slower oxygen-dependent reaction forming additional protein-bound homocysteine. To determine the equilibrium binding capacity of plasma proteins for homocysteine, plasma was treated with 0.5-10 mM dl-homocysteine for 4 h at 37 degrees C under aerobic conditions. Under these conditions the equilibrium binding capacity was 4.88 +/- 0.51 and 4.74 +/- 0.68 micromol/g protein for male (n = 10) and female (n = 10) donors, respectively. The mechanism of protein-bound homocysteine formation involves both thiol-disulfide exchange and thiol oxidation reactions. We conclude that plasma proteins have a high capacity for binding homocysteine in vitro. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062011     DOI: 10.1006/bbrc.2000.3723

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  The relationship between the concentration of plasma homocysteine and chronic kidney disease: a cross sectional study of a large cohort.

Authors:  Eytan Cohen; Ili Margalit; Tzippy Shochat; Elad Goldberg; Ilan Krause
Journal:  J Nephrol       Date:  2019-06-05       Impact factor: 3.902

2.  A rationale for cystine supplementation in severe homocystinuria.

Authors:  P J Lee; A Briddon
Journal:  J Inherit Metab Dis       Date:  2006-12-20       Impact factor: 4.982

3.  Redox-sensitive contrast agents for MRI based on reversible binding of thiols to serum albumin.

Authors:  Natarajan Raghunand; Bhumasamudram Jagadish; Theodore P Trouard; Jean-Philippe Galons; Robert J Gillies; Eugene A Mash
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

4.  Vascular smooth muscle cell differentiation to an osteogenic phenotype involves matrix metalloproteinase-2 modulation by homocysteine.

Authors:  Tingjiao Liu; Jinghan Lin; Ting Ju; Lei Chu; Liming Zhang
Journal:  Mol Cell Biochem       Date:  2015-05-19       Impact factor: 3.396

Review 5.  Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences.

Authors:  J David Spence; Bradley L Urquhart
Journal:  Curr Neurol Neurosci Rep       Date:  2022-10-01       Impact factor: 6.030

6.  Homocystinuria due to cystathionine beta-synthase deficiency: novel biochemical findings and treatment efficacy.

Authors:  M Orendác; J Zeman; S P Stabler; R H Allen; J P Kraus; O Bodamer; S Stöckler-Ipsiroglu; J Kvasnicka; V Kozich
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

7.  Age-associated perturbations in glutathione synthesis in mouse liver.

Authors:  Dikran Toroser; Rajindar S Sohal
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

8.  Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy.

Authors:  Zizhen Li; Qianqian Han; Hongbo Ye; Jiajia Li; Xiaona Wei; Rui Zhang; Qiuyan Huang; Yanchun Xu; Guanxian Liu; Bin Li; Qiongqiong Yang
Journal:  BMC Nephrol       Date:  2022-02-23       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.